Clinical Trial Update: A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants [Phase 1]

View source ↗

Summary

This clinical trial update reports the withdrawal of a Phase 1 study evaluating AN0025 in combination with chemoradiation therapy for stage III non-small cell l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AN0025

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Lung Cancer Stage III | Phase 1 | Status: WITHDRAWN